Montelukast Prescribing at STANMORE HOUSE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
558
Total Quantity
29.7K
NHS Cost
£1.4K
vs National Avg
-18.5%
STANMORE HOUSE SURGERY prescribed 558 items of Montelukast over the last 12 months at a cost of £1,421 to the NHS. This is 18.5% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
57
Jul 2026
48
Jul 2026
46
Jul 2026
55
Jul 2026
47
Jul 2026
48
Jul 2026
47
Jul 2026
36
Jul 2026
48
Jul 2026
43
Jul 2026
44
Jul 2026
39
Prescribing Details
| Total Items | 558 |
|---|---|
| Total Quantity | 29,652 |
| Total NHS Cost | £1,421 |
| Presentations | 4 different forms |
| vs National Average | -18.5% |
Montelukast Prescribing Comparison
| This practice | 558 items |
|---|---|
| National average per practice | 685 items |
| Difference | -18.5% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.